Editorial
Methicillin-resistant Staphylococcus aureus: An Established Pathogen with Emerging Infections
Abstract
Despite the general improvement in public health, the use of potent antimicrobial agents, and the strict application of hospital infection-control measures, the prevalence of methicillin-resistantStaphylococcus aureus (MRSA) continues to increase with multidrug resistance as a common phenotype. Analysis of data obtained from The Surveillance Network-USA (TSN), an electronic surveillance network that collects microbiology data from 300 clinical microbiology laboratories across the United States, showed that as of March 2005, MRSA rates were 59.2%, 55%, and 47.9% for strains from non-ICU inpatients, ICU, and outpatients, respectively.1 Mainous et al reported an estimated population carriage of MRSA of 0.84%, or 2.2 million persons, of the noninstitutionalized US population, including children and adults.2This content is limited to qualifying members.
Existing members, please login first
If you have an existing account please login now to access this article or view purchase options.
Purchase only this article ($25)
Create a free account, then purchase this article to download or access it online for 24 hours.
Purchase an SMJ online subscription ($75)
Create a free account, then purchase a subscription to get complete access to all articles for a full year.
Purchase a membership plan (fees vary)
Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.